Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury

Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury

US Patent 7579188 · Granted Aug 25, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of cell membrane-bound signaling factors2025
Use of cell membrane-bound signaling factors2023
Oligodendrocytes derived from human embryonic stem cells for remyelination and t2020
Oligodendrocytes derived from human embryonic stem cells for remyelination and t2020
IP-10 antibodies and their uses2018
IP-10 antibodies and their uses2015
Stem cell growth media and methods of making and using same2013
IP-10 antibodies and their uses2012
Cardiomyocytes and methods of producing and purifying cardiomyocytes2012
Stem cell growth media and methods of making and using same2011
Oligodendrocytes derived from human embryonic stem cells for remyelination and t2007
Oligodendrocytes derived from human embryonic stem cells for remyelination and t2007